ION904

DRUG2 trials

Sponsors

Ionis Pharmaceuticals, Inc.

Conditions

Healthy VolunteersHypertension

Phase 1

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION904

CompletedNCT04731623

Ionis Pharmaceuticals, Inc.Healthy Volunteers

Start: 2021-02-26End: 2021-09-11Updated: 2022-08-09

Phase 2

A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension

CompletedNCT05314439

Ionis Pharmaceuticals, Inc.Hypertension

Start: 2022-04-29End: 2023-02-15Updated: 2023-12-22

Related Papers

Antisense Inhibition of Angiotensinogen With IONIS-AGT-L<sub>Rx</sub>: Results of Phase 1 and Phase 2 Studies.

2021-05-0352 citations